Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has manufactured dose form |
Oromucosal solution |
true |
Inferred relationship |
Some |
|
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Is a |
Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Salicylic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Anthraquinone glycoside (substance) |
true |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Anthraquinone glycoside (substance) |
true |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Salicylic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has concentration strength numerator value |
cinq |
false |
Inferred relationship |
Some |
2 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has concentration strength numerator value |
dix |
false |
Inferred relationship |
Some |
1 |
|
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|